Founder Group invests in Chongqing pharmaceutical project

Pharmaceuticals

Saturday, August 30, 2008 06:01:30

	Founder Group invests in Chongqing pharmaceutical project By STAFF EDITOR Published: July 11, 2008 07:03 PM Founder Group, the parent company of Shanghai-listed Founder Technology (SHA 600601), will invest US$365.35 (RMB2.5 billion) in a pharmaceutical base in southwestern China’s Chongqing municipality, Xinhua reported. The company is aiming to become a leading biochemical supplier to the southwestern China market in ... You are currently reading 45 words of 138 total words in this article. To continue reading this article, you must be a subscriber. Log in now. Buy this article now for $10 USD. Not a subscriber? Start your 7-day free trial now. bookmark \| digg \| Permalink \| Tell a Friend Tags for this article: Shenzhen	More Articles in Pharmaceuticals > Today’s Daily Briefs E-Mail Sign up for a roundup of the day’s top stories, sent every day. RELATED ARTICLES > Tianjin railway firm sells Shenzhen branch to drugmaker Water Demands Boost Beijing Capital Apeloa subsidiaries buy Zhejiang land for drug R&D Beijing drugmaker sees 1H net profit rise 30% Sinopharm denies 4Q HK IPO Fosun Pharm 1H net profit up 144% Fosun Pharm 1H net profit up 144%

LOGIN AGRICULTURE AND FOOD AUTOMOTIVE AVIATION BANKING, FINANCE AND INSURANCE CHEMICALS CONSUMER AND RETAIL DEMOGRAPHICS EDITOR'S BLOG ENERGY HEAVY INDUSTRY INFRASTRUCTURE AND CONSTRUCTION INVESTMENT LEGAL AND REGULATORY LOGISTICS AND TRANSPORT MACROECONOMICS NATURAL RESOURCES AND COMMODITIES PHARMACEUTICALS POLITICS REAL ESTATE STOCK MARKETS TELECOMMUNICATIONS, MEDIA AND TECHNOLOGY TEXTILES TRADE ABOUT US Affiliates Contact Us HELP Privacy Policy Terms of Use

Browse by Title
1 2 3 4 5 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z